Can a Full-Body scan and blood test spot cancer early? new study aims to find out
NCT ID NCT05868486
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether whole body MRI scans and liquid biopsies (blood tests) are acceptable to people with a strong family history of cancer. Researchers want to see if these tools can help find early-stage cancers that standard screenings might miss. The study involves 100 participants and focuses on how satisfied they are with the process, not yet on whether the tests actually detect cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Whole body MRI and liquid biopsy
What this could lead to
If successful, this could show that combining whole body MRI and liquid biopsies is a feasible way to detect early cancers in high-risk individuals, potentially leading to earlier diagnosis.
What could go wrong
This is a very early feasibility study with only 100 participants. It measures patient satisfaction, not cancer detection rates, so it may not prove these tests actually find cancers earlier or save lives.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States